AIM:To investigate the short-term efficacy and safety of inebilizumab for neuromyelitis optica spectrum disorders(NMOSD).METHODS:A total of 33 patients with NMOSD treated with inebilizumab(Group INB,n=15)or rituximab(...
Supported by Natural Science Foundation of Beijing(No.7222025);Beijing Hospitals Authority’Ascent Plan(No.DFL20190201);Natural Science Foundation of Beijing Projects(No.81602408).
AIM:To evaluate the relationship between gene polymorphism(BclI,ER22/23EK,N363S)and the occurrence,progression and sensitivity to glucocorticoid of lacrimal gland benign lymphoepithelial lesion(LGBLEL).METHODS:Clinica...
Supported by the Natural Science Foundation of China(No.81770926);the Natural Key Research and Development Program of China(No.2016YFC1101200)。
To assess all available data to compare the efficacy of glucocorticoids treatment and orbital decompression for dysthyroid optic neuropathy(DON).PubMed,EMBASE,the Cochrane Library databases as well as other sources we...
Supported by the National Natural Science Foundation of China (No.81670885);the Science and Technology Program of Guangdong Province, China (No.2013B020400003);the Science and Technology Program of Guangzhou, China (No.15570001)
AIM: To report the effects of intravenous high-dose glucocorticoids(iv GC) and orbital decompression(OD) surgery for treatment of sight-threatening thyroid-associated ophthalmopathy(TAO).METHODS: A retrospective revie...
Supported by National Natural Science Foundation of China(No.81170874)
AIM: To evaluate the benefit and harms of high-dose intravenous glucocorticoids(IVGC) as first-line treatment for Graves’ ophthalmopathy(GO).METHODS: A systematic review and Meta-analysis of randomized clinical trial...
Supported by Technology Planning Project of Guangdong Province,China(No.2015B020211004)
AIM: To evaluate the efficacy and safety of combined anti-vascular endothelial growth factor (VEGF) agents, oral glucocorticoid, and laser photocoagulation therapy for macular edema (ME) secondary to retinal vein...
Central serous chorioretinopathy (CSC) is characterized by a localized accumulation of subretinal fluid and an idiopathic focal leakage from choroidal vessels. The exact pathogenesis of CSC, however, still remains o...